NEW ORLEANS-An in-depth assessment of PET/CT at two German teaching hospitals has shown the fusion imaging technology improves on CT alone and pays dividends clinically and financially for staging non-small-cell lung cancer.
Alison Fromme
Advertisement
Articles by Alison Fromme
Advertisement
Latest Updated Articles
- PET/CT shows high value in lung cancer staging trial
Published: November 1st 2008 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Clears IND Application for Novel IL-2 Agent in Advanced NSCLC
2
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
3
Novel TLR Coagonist Combo Shows Responses in Stage IV NSCLC
4
Future of PCI: PCI vs MRI surveillance
5
